NASDAQ:ENOB

Enochian Biosciences, Inc.

Stock

USD

Last Close

0.70

04/08 19:58

Market Cap

45.38M

Beta: 1.09

Volume Today

87.29K

Avg: 57.04K

PE Ratio

0.00

PFCF: −3.61

Overview Analysis Financials Filings people API Chart Data

Income Statement Balance Sheet Cash Flow Key Metrics Ratios

Excel Tearsheet

Quarterly

Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe Now Help

	Jun '22	Jun '23
net income	-113.43M -	-39.68M 65.02%
depreciation and amortization	123.59K -	113.50K 8.17%
deferred income tax
stock based compensation	5.49M -	3.54M 35.62%
change in working capital	1.42M -	4.31M 204.23%
accounts receivables
inventory
accounts payables	1.08M -	3.89M 260.21%
other working capital
other non cash items	-2.60M -	995.80K 138.31%
net cash provided by operating activities	-15.73M -	-11.77M 25.16%
investments in property plant and equipment	-5.16K -	-29.77K 477.46%
acquisitions net
purchases of investments
sales maturities of investments
other investing activites
net cash used for investing activites	-5.16K -	-29.77K 477.46%
debt repayment	-560.85K -	-1.12M 100.01%
common stock issued	4.68M -	4.01M 14.21%
common stock repurchased
dividends paid
other financing activites
net cash used provided by financing activities	4.25M -	4.52M 6.23%
effect of forex changes on cash	-5.24K -	-8.39K 60.21%
net change in cash	-11.49M -	-7.30M 36.50%
cash at beginning of period	20.66M -	9.17M 55.61%
cash at end of period	9.17M -	1.87M 79.56%
operating cash flow	-15.73M -	-11.77M 25.16%
capital expenditure	-5.16K -	-29.77K 477.46%
free cash flow	-15.74M -	-11.80M 24.99%

All numbers in USD (except ratios and percentages)